dizziness on semaglutide Is Vertigo a Side Effect of Wegovy? Balance Issues Explained The Risk of Vestibular Disorders

Description

A 2021 meta-analysis of the SUSTAIN and PIONEER trialsthe clinical trial programs used to assess semaglutides effectiveness in people with Type 2 diabetesfound that semaglutide use increased deep vein thrombosis (DVT) by 266%

Its a clinical consideration that requires oversight by providers

Curtis is board-certified in internal medicine and obesity medicine, and he is known for his expertise in personalized, preventive care and metabolic health

The protective effect of GLP-1 RAs was particularly evident in patients with obesity (aHR: 0.61, 95% CI: 0.500.77), whereas no significant benefit was noted in non-obese individuals (aHR: 0.94, 95% CI: 0.671.31)